Rebaudioside A Uses, Dosage, Side Effects and more
Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).
| Trade Name | Rebaudioside A |
| Generic | Rebaudioside A |
| Type | |
| Formula | C44H70O23 |
| Weight | Average: 967.021 Monoisotopic: 966.430788514 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
